AU Patent

AU3588693A — N-benzyloxamic acid, oxamate, and oxamide derivatives and their use as TNF and PDE IV inhibitors

Assigned to SmithKline Beecham Corp · Expires 1993-09-01 · 33y expired

What this patent protects

Patent listed against Trulance.

Drugs covered by this patent

Patent Metadata

Patent number
AU3588693A
Jurisdiction
AU
Classification
Expires
1993-09-01
Drug substance claim
No
Drug product claim
No
Assignee
SmithKline Beecham Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.